Avelos Therapeutics Inc. announced that it has received $8 million in funding from UTC Investment Co., Ltd., Mirae Asset Venture Investment Co., Ltd., SV Investment Corporation, Quad Investment Management Corp., Mirae Asset Capital Co,Ltd., Investment Arm
August 21, 2022
Share
Avelos Therapeutics Inc. announced that it has raised $8 million in a round of funding on August 22, 2022. The Transaction included the participation from SV Investment Corporation, UTC Investment Co., Ltd., Quad Investment Management Corp., Mirae Asset Venture Investment Co., Ltd., Mirae Asset Capital Co,Ltd., Investment Arm and Timepolio Asset Management.
Mirae Asset Venture Investment Co., Ltd is a Korea-based venture capital (VC) firm engaged in the investment in small to medium enterprises (SMEs). The Company principally engaged in the investment in SMEs and venture companies, overseas investment, establishment and management of business incubation centers, as well as formation of private equity funds (PEFs). The Company also provides initial public offering (IPO), merger and acquisitions (M&A), business management, consulting and restructuring services.
Avelos Therapeutics Inc. announced that it has received $8 million in funding from UTC Investment Co., Ltd., Mirae Asset Venture Investment Co., Ltd., SV Investment Corporation, Quad Investment Management Corp., Mirae Asset Capital Co,Ltd., Investment Arm